Quanterix Launches LucentAD Biomarker Blood Test to Aid Physician Diagnosis of Alzheimer’s Disease…
Test will play an important role in the evaluation of patients experiencing cognitive symptoms consistent with early signs of Alzheimer’s diseaseBILLERICA, Mass., July 06, 2023--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a…